Des-gamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Des-gamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma.

Des-gamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma.

http://www.wikidata.org/entity/Q40483903

about

Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation Vitamin K and hepatocellular carcinoma: The basic and clinic Hereditary combined deficiency of the vitamin K-dependent clotting factors.Serum tumor markers for detection of hepatocellular carcinoma.Protein induced by vitamin K absence or antagonist II-producing gastric cancer.Role of vitamins in gastrointestinal diseases.Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma.Growth inhibitory actions of prothrombin on normal hepatocytes: influence of matrix.Targeting the HGF/c-MET pathway in hepatocellular carcinoma.An overview of biomarkers for the diagnosis of hepatocellular carcinoma.Des-gamma-carboxy prothrombin as an important prognostic indicator in patients with small hepatocellular carcinoma.Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics.Significant biomarkers for the management of hepatocellular carcinoma.The Therapeutic Targeting of HGF/c-Met Signaling in Hepatocellular Carcinoma: Alternative Approaches.Effect of sorafenib on des-γ-carboxyprothrombin secretion by a human hepatocellular carcinoma cell line.Detection of subclinical vitamin K deficiency in neurosurgery with PIVKA-II.Trends in the development of MET inhibitors for hepatocellular carcinoma.Poly-(ADP-Ribose) Polymerase-1 Promotes Prothrombin Gene Transcription and Produces Des-Gamma-Carboxy Prothrombin in Hepatocellular Carcinoma.c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma.Roles and Signaling Pathways of Des-γ-Carboxyprothrombin in the Progression of Hepatocellular Carcinoma.Clinical application of protein induced by vitamin K antagonist-II as a biomarker in hepatocellular carcinoma.Des-γ-carboxyl prothrombin is associated with tumor angiogenesis in hepatocellular carcinoma.Combined measurement of preoperative α-fetoprotein and des-γ-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma.Des-gamma-carboxyl prothrombin-promoted vascular endothelial cell proliferation and migration.Exon 2 deletion splice variant of gamma-glutamyl carboxylase causes des-gamma-carboxy prothrombin production in hepatocellular carcinoma cell lines Clinical Impact of Vitamin K Dosing on Sorafenib Treatment for Hepatocellular Carcinoma.Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways.Menahydroquinone-4 Prodrug: A Promising Candidate Anti-Hepatocellular Carcinoma Agent.Attenuation of MET-mediated migration and invasion in hepatocellular carcinoma cells by SOCS1.NX-PVKA assay, a conventional but refined prognostic biomarker for hepatocellular carcinoma.Novel des-γ-carboxy prothrombin in serum for the diagnosis of hepatocellular carcinoma.Development of des-gamma-carboxy prothrombin (DCP) measuring reagent using the LiBASys clinical analyzer.Vitamin K and cancer.Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size.Clinical usefulness of double biomarkers AFP and PIVKA-II for subdividing prognostic groups in locally advanced hepatocellular carcinoma.Comparative evaluation of expanded criteria for patients with hepatocellular carcinoma beyond the Milan criteria undergoing living-related donor liver transplantation.Microvascular invasion of single small hepatocellular carcinoma ≤3 cm: Predictors and optimal treatments.Macroscopic Portal Vein Thrombosis in HCC Patients.

P2860

Q26772329-08C57AD9-79B1-4D0A-9C4B-2F72F79779FD Q26783713-9A7B656A-41BD-4D6B-8E19-CFA289C7CAE3 Q34035983-E7B18F07-351B-4B60-A545-62A807E4CB89 Q34501851-B7AFFCFB-3848-44F4-AC63-A90CE8A2121C Q34992363-CA9BF13A-1414-409B-8C3F-FF20696D8CFB Q35567624-FD473F7E-5DEC-46A4-97CF-B5C2A0F73921 Q35633563-05B75338-7D43-49E5-9B95-B325FF8AFEE0 Q35951527-4715FB63-17CC-4149-AA86-69987E390570 Q36093497-39420B83-C6A6-4EE3-96DE-6125FB08BB02 Q36395289-D77783D9-D35A-4E49-86E5-12FB8B3DB3D8 Q37220662-EBFCDAF5-977B-45D5-9D7F-8A0965F96C1A Q37856310-256FAE79-FF8B-4DE8-9BCA-55BFF4DD3D94 Q38412315-029BCED2-3410-45DE-8C20-0E61C260A438 Q38674137-3ADAF3FD-BF3A-48BD-AC69-8B7C31CE43C4 Q38695636-B9A756B2-43AD-466F-84F8-9C2003A8CC87 Q38742818-4DB63443-7983-4829-A76B-7172FD04DA3A Q38777675-3D2A4271-8371-4A5E-B4F9-ABB7C4D87D4F Q38849845-D8544305-2E16-4348-AB2A-6C15871553A5 Q38923535-91556718-D07B-44D6-8183-2A349708D6FA Q38965626-359B6D1C-5CB0-4172-8CF0-0035E867A61C Q38980072-810B1B86-9174-41A9-B7F1-DEDD791B2429 Q39354326-B87F9B3C-47D3-48A1-B6F3-47B078195F17 Q39648514-00920778-2605-4D56-892D-0CB6C01E6A1A Q40178858-72E1002F-1F27-4F90-BDA5-4C7A1284369A Q41129811-48358995-9948-461E-AF53-1265BB3D65DE Q41439834-46A78313-0C68-4BDF-80A1-8EAB0E29A1CE Q41667581-7E80C036-2980-4415-8210-6F907E868767 Q42343446-AB393142-39BC-4613-9473-1F6FF492BD0D Q42695141-E0C3AAAD-A294-46CA-B11E-FAF70CD1E411 Q44000482-715F6585-D511-471B-8F58-7F132E888CE7 Q44853190-5B24F7B9-9F5E-424A-A78A-4F2D02F90131 Q46768562-032B667D-A0A5-4974-8BD2-E5D0C4BF4D05 Q47249966-0A3FB72C-72BF-4E16-81C6-B38B09E8633A Q47329577-98615A63-4BFE-421B-A6E6-79FDD59F7677 Q47911866-73A11910-9BF9-4EC8-9CC4-228418A59325 Q51037602-FEAA7EB4-1272-4093-A5DD-7B8F3290186F Q55233905-637CB2CE-D8A7-4FA0-BAC9-AFE7E73C266C Q55712348-C38FC9DF-2306-4A94-9718-98B2255B64C3

P2860

Des-gamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma.

http://www.wikidata.org/entity/Q40483903

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Des-gamma-carboxy prothrombin ...... for hepatocellular carcinoma.

@en

type

label

Des-gamma-carboxy prothrombin ...... for hepatocellular carcinoma.

@en

prefLabel

Des-gamma-carboxy prothrombin ...... for hepatocellular carcinoma.

@en

P1433

Q40483903-00B9E188-C4CB-4A6C-9BC4-880AE8C3D9EC

P1476

Q40483903-D5ACBC0B-680A-4F90-A0EA-42F7EEC97606

P2093

Q40483903-1A077832-6DD2-486B-970A-BBC51314B2C1

Q40483903-22F5EE35-8B24-460B-A071-4252D8E49EF0

Q40483903-6AEFB3FA-AEC4-4058-ABF6-8669838F3713

Q40483903-7EE2908B-38D2-4CDA-9B2F-B63E177CB71E

Q40483903-8879873A-CE12-4034-8ADF-9992E3EDF545

Q40483903-8902FEAD-2377-472B-99BB-E184BB88405C

Q40483903-A2A4F3A2-E4CD-4C03-8CBB-1AF392CE2DF7

Q40483903-A3649C2F-991E-409B-8F25-1803159403BB

Q40483903-C3C6AAB3-7527-4AA9-B1F7-DDDD028DC2EF

P2860

Q40483903-0E7CFCEE-D003-45BC-9873-2A9C447B6D22

Q40483903-0FE04A2B-4B94-4F5D-9A6F-A0BB7F0FFA7F

Q40483903-27E837D4-DB3D-489D-9BD4-CE9CAA3BDB1C

Q40483903-3292303D-F057-4D70-905B-109545CFFA77

Q40483903-382F66D4-AC22-415D-9F57-0C53DBA4A484

Q40483903-463A0467-9C88-4790-9110-9F9E391D8035

Q40483903-4831BD33-0556-439F-8C8E-1B6926073A5E

Q40483903-56036A48-57A2-45F6-A946-76486EFC84A1

Q40483903-58CB14B8-B288-4526-BAB6-6871D5BE6AF0

Q40483903-5A50CA0B-0D8F-484D-85A6-4D90FB631186

P304

Q40483903-46393C18-2931-4ACF-BA0E-8AB56870C140

P31

Q40483903-33A6411C-2381-42FB-8B73-8EC46B03FA20

P356

Q40483903-9E6A772A-C5F9-45F6-B131-365D52048983

P407

Q40483903-C330851C-A071-4E7D-BA0E-5B892B39A11D

P433

Q40483903-6049F8B3-8B4A-44D8-9431-1CF6C8861B4F

P478

Q40483903-B0DD17DF-8A6B-4090-9C76-D27C6B93D004

P577

Q40483903-9EA5B38F-0FC4-4F00-938D-E9DC41BBCE26

P698

Q40483903-413A120E-B4DA-4622-ACDF-524202C18409

P356

P1433

Journal of Biological Chemistry

P1476

Des-gamma-carboxy prothrombin ...... for hepatocellular carcinoma.

@en

P2093

Akinobu Takaki

http://www.w3.org/2001/XMLSchema#string

Hidenori Shiraha

http://www.w3.org/2001/XMLSchema#string

Kazuko Koike

http://www.w3.org/2001/XMLSchema#string

Mayumi Suzuki

http://www.w3.org/2001/XMLSchema#string

Naoki Ueda

http://www.w3.org/2001/XMLSchema#string

Nobuyuki Takaoka

http://www.w3.org/2001/XMLSchema#string

Tatsuya Fujikawa

http://www.w3.org/2001/XMLSchema#string

Yasushi Shiratori

http://www.w3.org/2001/XMLSchema#string

Yutaka Nakanishi

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning and expression of human hepatocyte growth factor

Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product

STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation

Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR

Serine phosphorylation and negative regulation of Stat3 by JNK

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients

Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma

A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family

P304

6409-6415

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M406714200

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

280

http://www.w3.org/2001/XMLSchema#string

P577

2004-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15582995

http://www.w3.org/2001/XMLSchema#string